Excited to share our new Nature paper on in vivo CAR-NK CRISPRa screen + discovery of a hyperbooster for solid tumor https://t.co/J4gBc5aYDM Tx to Luojia, Paul, Drs Peng, Gunel, Moliterno, J Chen. #NK cell therapy @Yalegenetics@yalewestcampus@yalemed@yalecancer@yneurosurgery
Proud to present our work at #KCRS25 on CAR-T screens, cell therapy and kidney cancer from @YaleMed@YaleGenetics@YaleWestCampus@YaleCancer Honored to be in session with Drs. Chuck Drake at JnJ, Nadal Rios at Hutch & Patrick Ott at Farber, hosted by David Braun &Hans Hammers.
#KCRS25 Session 6 highlighted how researchers are pushing the boundaries of what immunotherapy can do for kidney cancer patients.
Engaging Native Immunity with ENPP3 with Chuck Drake
TCR-Engineered Cell Therapy with @RosaNadalrios
Next Generation T-Cell Engineering with @sidichen
Future of Cancer Vaccines with Patrick Ott
#AcceleratingCures
🎉 CRI is proud to announce the 2025 CLIP and Technology Impact Award projects, a new class of high‑potential studies and tools designed to push cancer immunotherapy further and faster! Explore: https://t.co/k9UzH3v2zy #Immunotherapy#CancerResearch#CancerResearcher
Our lab generated 4 new lines of Cas12a transgenic mice and demonstrated utility in immune engineering, tumor modeling, and genetic disease treatment. Around to share w the field & community! @YaleMed@YaleWest@YaleGenetics@YaleData Also @LabWinslow https://t.co/LROOO0qmF8
“Building a community and paying attention to that community is the essence of getting things done.”
Today #JameelClinic Advisory Board Chair and Nobel laureate Phil Sharp celebrated the 50th anniversary of his lab, “The Sharpies” — half a century of sharp minds!
Our new high fidelity enhanced AsCas12a/Cpf1 transgenic mice after five years of work. Generated by Matt Dong and colleagues here in lab at @YaleGenetics@YaleCancer@YaleMed@YaleWestCampus Anyone who want to try them out feel free to please contact us. https://t.co/Wxtuq1ju2Z